Diagnexia and Stratipath Partner to Expand AI-Based Cancer Precision Diagnostics Across the UK and Europe
1 April 2025
Diagnexia, and Stratipath AB are pleased to announce a strategic
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Diagnexia, and Stratipath AB are pleased to announce a strategic
Stratipath is proud to announce that globally recognized breast oncologist,
Stratipath has been recognized as one of the Gold Companies
Capio St Göran’s Hospital is one of the largest breast
SwAIPP 2, the continuation of the SwAIPP project, has been
Johan Hartman is a guest at the Johnson & Johnson
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic
Diagnexia, and Stratipath AB are pleased to announce a strategic
Johan Hartman is a guest at the Johnson & Johnson
Johan Hartman is a guest at the Johnson & Johnson
Advances in breast cancer research are providing entirely new opportunities